메뉴 건너뛰기




Volumn 73, Issue 11, 2016, Pages 1173-1179

Association between continued cannabis use and risk of relapse in first-episode psychosis a quasi-experimental investigation within an observational study

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; CANNABINOID;

EID: 84997822659     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2016.2427     Document Type: Article
Times cited : (74)

References (40)
  • 2
    • 84997687735 scopus 로고    scopus 로고
    • The worst of both worlds: The Wild West of the legal marijuana industry
    • Scheuer LM. The worst of both worlds: The Wild West of the legal marijuana industry. North Ill Univ Law Rev. 2015;35(3):557-574.
    • (2015) North Ill Univ Law Rev , vol.35 , Issue.3 , pp. 557-574
    • Scheuer, L.M.1
  • 3
    • 84997657728 scopus 로고    scopus 로고
    • 1bn a year, lib dem review group says Updated March 8 2016 Accessed June 19, 2016
    • Waugh P. Legalising cannabis and selling it over the counter could raise 1bn a year, lib dem review group says. http://www.huffingtonpost.co.uk/2016/03/07/legalise-cannabis-liberal-democrats-Tim-farron-mike-barton-david-nutt-n-9404346.html. Updated March 8, 2016. Accessed June 19, 2016.
    • Legalising Cannabis and Selling It over the Counter Could Raise
    • Waugh, P.1
  • 5
    • 84871070051 scopus 로고    scopus 로고
    • Common values in assessing health outcomes from disease and injury: Disabilityweights measurement study for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]
    • Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disabilityweights measurement study for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012;380(9859):2129-2143.
    • (2012) Lancet , vol.380 , Issue.9859 , pp. 2129-2143
    • Salomon, J.A.1    Vos, T.2    Hogan, D.R.3
  • 6
    • 84887259083 scopus 로고    scopus 로고
    • Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010
    • Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382 (9904):1575-1586.
    • (2013) Lancet , vol.382 , Issue.9904 , pp. 1575-1586
    • Whiteford, H.A.1    Degenhardt, L.2    Rehm, J.3
  • 7
    • 1842866942 scopus 로고    scopus 로고
    • Relapse in schizophrenia: Costs, clinical outcomes and quality of life
    • Almond S, Knapp M, Francois C, Toumi M, Brugha T. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry. 2004; 184(4):346-351.
    • (2004) Br J Psychiatry , vol.184 , Issue.4 , pp. 346-351
    • Almond, S.1    Knapp, M.2    Francois, C.3    Toumi, M.4    Brugha, T.5
  • 8
    • 67650495255 scopus 로고    scopus 로고
    • Impact of psychotic relapse definitions in assessing drug efficacy and costs: Comparison of quetiapine XR, olanzapine and paliperidone ER
    • Knapp M, Locklear J, Jbrink K. Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER. Curr Med Res Opin. 2009;25(7):1593-1603.
    • (2009) Curr Med Res Opin , vol.25 , Issue.7 , pp. 1593-1603
    • Knapp, M.1    Locklear, J.2    Jbrink, K.3
  • 9
    • 84865998027 scopus 로고    scopus 로고
    • Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis
    • Faridi K, Joober R, Malla A. Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis. Schizophr Res. 2012;141(1):78-82.
    • (2012) Schizophr Res , vol.141 , Issue.1 , pp. 78-82
    • Faridi, K.1    Joober, R.2    Malla, A.3
  • 10
    • 78650154703 scopus 로고    scopus 로고
    • Rate of cannabis use disorders in clinical samples of patients with schizophrenia: Ameta-Analysis
    • Koskinen J, Len J, Koponen H, Isohanni M, Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: Ameta-Analysis. Schizophr Bull. 2010;36(6): 1115-1130.
    • (2010) Schizophr Bull , vol.36 , Issue.6 , pp. 1115-1130
    • Koskinen, J.1    Len, J.2    Koponen, H.3    Isohanni, M.4    Miettunen, J.5
  • 11
    • 84990229660 scopus 로고    scopus 로고
    • United National Office on Drugs and Crime Washington DC United Nations Office on Drugs and Crime
    • United National Office on Drugs and Crime. World Drug Report 2015.Washington, DC: United Nations Office on Drugs and Crime; 2015.
    • (2015) World Drug Report 2015
  • 12
    • 84959576716 scopus 로고    scopus 로고
    • Continued versus discontinued cannabis use in patients with psychosis: A systematic review and meta-Analysis
    • Schoeler T, Monk A, Sami MB, et al. Continued versus discontinued cannabis use in patients with psychosis: A systematic review and meta-Analysis. Lancet Psychiatry. 2016;3(3):215-225.
    • (2016) Lancet Psychiatry , vol.3 , Issue.3 , pp. 215-225
    • Schoeler, T.1    Monk, A.2    Sami, M.B.3
  • 13
    • 84966549733 scopus 로고    scopus 로고
    • Correlation still does not imply causation
    • Ksir C, Hart CL. Correlation still does not imply causation. Lancet Psychiatry. 2016;3(5):401.
    • (2016) Lancet Psychiatry , vol.3 , Issue.5 , pp. 401
    • Ksir, C.1    Hart, C.L.2
  • 14
    • 84966480792 scopus 로고    scopus 로고
    • Correlation still does not imply causation: Authors reply
    • Schoeler T, Murray R, Bhattacharyya S. Correlation still does not imply causation: Authors reply. Lancet Psychiatry. 2016;3(5):401-402.
    • (2016) Lancet Psychiatry , vol.3 , Issue.5 , pp. 401-402
    • Schoeler, T.1    Murray, R.2    Bhattacharyya, S.3
  • 15
    • 77955355100 scopus 로고    scopus 로고
    • Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization
    • Foti DJ, Kotov R, Guey LT, Bromet EJ. Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am J Psychiatry. 2010;167(8):987-993.
    • (2010) Am J Psychiatry , vol.167 , Issue.8 , pp. 987-993
    • Foti, D.J.1    Kotov, R.2    Guey, L.T.3    Bromet, E.J.4
  • 16
    • 34347234817 scopus 로고    scopus 로고
    • The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: Findings from a 10-month prospective study
    • Degenhardt L, Tennant C, Gilmour S, et al. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med. 2007;37 (7):927-934.
    • (2007) Psychol Med , vol.37 , Issue.7 , pp. 927-934
    • Degenhardt, L.1    Tennant, C.2    Gilmour, S.3
  • 17
    • 77952976236 scopus 로고    scopus 로고
    • Psychosis reactivity to cannabis use in daily life: An experience sampling study
    • Henquet C, van Os J, Kuepper R, et al. Psychosis reactivity to cannabis use in daily life: An experience sampling study. Br J Psychiatry. 2010;196(6): 447-453.
    • (2010) Br J Psychiatry , vol.196 , Issue.6 , pp. 447-453
    • Henquet, C.1    Van Os, J.2    Kuepper, R.3
  • 18
    • 84908504595 scopus 로고    scopus 로고
    • Genetic predisposition to schizophrenia associated with increased use of cannabis
    • Power RA, Verweij KJ, Zuhair M, et al. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry. 2014;19 (11):1201-1204.
    • (2014) Mol Psychiatry , vol.19 , Issue.11 , pp. 1201-1204
    • Power, R.A.1    Verweij, K.J.2    Zuhair, M.3
  • 19
    • 58349096548 scopus 로고    scopus 로고
    • Drawing conclusions about causes from systematic reviews of risk factors: The Cambridge Quality Checklists
    • Murray J, Farrington DP, Eisner MP. Drawing conclusions about causes from systematic reviews of risk factors: The Cambridge Quality Checklists. J Exp Criminol. 2009;5(1):1-23.
    • (2009) J Exp Criminol , vol.5 , Issue.1 , pp. 1-23
    • Murray, J.1    Farrington, D.P.2    Eisner, M.P.3
  • 20
    • 84960113186 scopus 로고    scopus 로고
    • Continuity of cannabis use and violent offending over the life course
    • Schoeler T, Theobald D, Pingault JB, et al. Continuity of cannabis use and violent offending over the life course. Psychol Med. 2016;46(8): 1663-1677.
    • (2016) Psychol Med , vol.46 , Issue.8 , pp. 1663-1677
    • Schoeler, T.1    Theobald, D.2    Pingault, J.B.3
  • 21
    • 84874885884 scopus 로고    scopus 로고
    • Dose-related psychotic symptoms in chronic methamphetamine users: Evidence from a prospective longitudinal study
    • McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatry. 2013;70(3):319-324.
    • (2013) JAMA Psychiatry , vol.70 , Issue.3 , pp. 319-324
    • McKetin, R.1    Lubman, D.I.2    Baker, A.L.3    Dawe, S.4    Ali, R.L.5
  • 22
    • 14944386553 scopus 로고    scopus 로고
    • Tests of causal linkages between cannabis use and psychotic symptoms
    • Fergusson DM, Horwood LJ, Ridder EM. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction. 2005;100(3):354-366.
    • (2005) Addiction , vol.100 , Issue.3 , pp. 354-366
    • Fergusson, D.M.1    Horwood, L.J.2    Ridder, E.M.3
  • 23
    • 77951853072 scopus 로고    scopus 로고
    • Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults
    • McGrath J, Welham J, Scott J, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010;67(5): 440-447.
    • (2010) Arch Gen Psychiatry , vol.67 , Issue.5 , pp. 440-447
    • McGrath, J.1    Welham, J.2    Scott, J.3
  • 24
    • 31844443695 scopus 로고
    • The environment and disease: Association or causation?
    • Hill AB. The environment and disease: Association or causation? Proc R Soc Med. 1965;58 (5):295-300.
    • (1965) Proc R Soc Med , vol.58 , Issue.5 , pp. 295-300
    • Hill, A.B.1
  • 25
    • 34547641049 scopus 로고    scopus 로고
    • Hospitalisation as an outcome measure in schizophrenia
    • Burns T. Hospitalisation as an outcome measure in schizophrenia. Br J Psychiatry Suppl. 2007;50(50):s37-s41.
    • (2007) Br J Psychiatry Suppl , vol.50 , Issue.50 , pp. s37-s41
    • Burns, T.1
  • 26
    • 84861585734 scopus 로고    scopus 로고
    • Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-Analysis
    • Leucht S, Tardy M, Komossa K, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-Analysis. Lancet. 2012;379(9831): 2063-2071.
    • (2012) Lancet , vol.379 , Issue.9831 , pp. 2063-2071
    • Leucht, S.1    Tardy, M.2    Komossa, K.3
  • 27
    • 76849096676 scopus 로고    scopus 로고
    • The cost of relapse and the predictors of relapse in the treatment of schizophrenia
    • Ascher-Svanum H, Zhu B, Faries DE, et al. The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry. 2010; 10(1):2.
    • (2010) BMC Psychiatry , vol.10 , Issue.1 , pp. 2
    • Ascher-Svanum, H.1    Zhu, B.2    Faries, D.E.3
  • 28
    • 84942244171 scopus 로고    scopus 로고
    • Perspective: Be clear about the real risks
    • Hill M. Perspective: be clear about the real risks. Nature. 2015;525(7570):S14.
    • (2015) Nature , vol.525 , Issue.7570 , pp. S14
    • Hill, M.1
  • 30
    • 0026410654 scopus 로고
    • A polydiagnostic application of operational criteria in studies of psychotic illness: Development and reliability of the OPCRIT system
    • McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry. 1991;48(8): 764-770.
    • (1991) Arch Gen Psychiatry , vol.48 , Issue.8 , pp. 764-770
    • McGuffin, P.1    Farmer, A.2    Harvey, I.3
  • 31
    • 84923298138 scopus 로고    scopus 로고
    • Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study
    • Di Forti M, Marconi A, Carra E, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study. Lancet Psychiatry. 2015;2(3):233-238.
    • (2015) Lancet Psychiatry , vol.2 , Issue.3 , pp. 233-238
    • Di Forti, M.1    Marconi, A.2    Carra, E.3
  • 32
    • 84886075606 scopus 로고    scopus 로고
    • Definitions and drivers of relapse in patients with schizophrenia: A systematic literature review
    • Olivares JM, Sermon J, Hemels M, Schreiner A. Definitions and drivers of relapse in patients with schizophrenia: A systematic literature review. Ann Gen Psychiatry. 2013;12(1):32.
    • (2013) Ann Gen Psychiatry , vol.12 , Issue.1 , pp. 32
    • Olivares, J.M.1    Sermon, J.2    Hemels, M.3    Schreiner, A.4
  • 33
    • 84883196026 scopus 로고    scopus 로고
    • Relationship between relapse and hospitalization in first-episode psychosis
    • Addington DE, Patten SB, McKenzie E, Addington J. Relationship between relapse and hospitalization in first-episode psychosis. Psychiatr Serv. 2013;64(8):796-799.
    • (2013) Psychiatr Serv , vol.64 , Issue.8 , pp. 796-799
    • Addington, D.E.1    Patten, S.B.2    McKenzie, E.3    Addington, J.4
  • 34
    • 84863776224 scopus 로고    scopus 로고
    • Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-Analysis of longitudinal studies
    • Alvarez-Jimenez M, Priede A, Hetrick SE, et al. Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-Analysis of longitudinal studies. Schizophr Res. 2012;139(1-3):116-128.
    • (2012) Schizophr Res , vol.139 , Issue.1-3 , pp. 116-128
    • Alvarez-Jimenez, M.1    Priede, A.2    Hetrick, S.E.3
  • 38
    • 84973346045 scopus 로고    scopus 로고
    • Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks
    • Sherva R, WangQ, Kranzler H, et al. Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks. JAMA Psychiatry. 2016;73(5): 472-480.
    • (2016) JAMA Psychiatry , vol.73 , Issue.5 , pp. 472-480
    • Sherva, R.1    Wang, Q.2    Kranzler, H.3
  • 39
    • 0026029607 scopus 로고
    • Drug abuse in schizophrenic patients: Clinical correlates and reasons for use
    • Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry. 1991;148(2):224-230.
    • (1991) Am J Psychiatry , vol.148 , Issue.2 , pp. 224-230
    • Dixon, L.1    Haas, G.2    Weiden, P.J.3    Sweeney, J.4    Frances, A.J.5
  • 40
    • 84955469036 scopus 로고    scopus 로고
    • Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review
    • Wilson RP, Bhattacharyya S. Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review. J Psychopharmacol. 2016;30(2):99-111.
    • (2016) J Psychopharmacol , vol.30 , Issue.2 , pp. 99-111
    • Wilson, R.P.1    Bhattacharyya, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.